Clinical trial
Adoptive Immunotherapy for CMV Disease
NCT00159055 · Hadassah Medical Organization, Other · Withdrawn
Key facts
| NCT number | NCT00159055 |
|---|---|
| Title | Adoptive Immunotherapy for CMV Disease |
| Official title | Prevention and Treatment of CMV Disease by Adoptive Immunotherapy With Immune Donor Lymphocytes in Conjunction With Non-myeloablative Stem Cell Transplantation (NST) |
| Lead sponsor | Hadassah Medical Organization, Other |
| Status | Withdrawn |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | CMV Disease |
| Intervention type | Biological |
| Interventions | CMV vaccine |
| Enrollment | 20 |
| Start date | Feb 1, 2004 |
| First posted | Sep 12, 2005 |
| Last update posted | Apr 8, 2011 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: